Metabolomic profile as a biomarker in early breast cancer patients candidate to neoadjuvant therapy

被引：0
|
作者：
Martini, V. [1 ]
Ruffilli, B. [2 ]
Di Lascio, S. [1 ]
D'Avanzo, F. [1 ]
Rossi, V. [1 ]
Gobbato, S. [2 ]
Vezzoli, F. [2 ]
Negrini, L. [2 ]
Alsati, R. [2 ]
Ben Ayed, R. [2 ]
Tarantino, G. [3 ]
Guarneri, V. [4 ]
Griguolo, G. [4 ]
Boldorini, R. L. [2 ]
Branni, C. [2 ]
Matera, L. [2 ]
Sala, N. [2 ]
Barberis, E. [2 ]
Manfredi, M. [2 ]
Gennari, A. [2 ]
机构：
[1] AOU Maggiore Carita, Dept Oncol, Novara, Italy
[2] Univ Piemonte Orientale, Translat Med, Novara, Italy
[3] Pharmanutra Spa, Pisa, Italy
[4] Univ Padua, Dept Surg Oncol & Gastroenterol, Padua, Italy
来源：
EUROPEAN JOURNAL OF CANCER | 2024年 / 200卷
关键词：
D O I：
10.1016/j.ejca.2024.113874
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
308 (PB-12
引用
收藏
页码：115 / 115
页数：1
相关论文
共 50 条
  • [31] Change in Biomarker Profile after neoadjuvant chemotherapy is especially common in patients with HER2+breast cancer subtype
    Gottipati, Soumy
    Baxter, Molly
    Chen, Yunn-yi
    Venters, Sara J.
    Goldbach, Macy
    Gonzalves, Diego
    Nayak, Anupma
    Mukhtar, Rita A.
    Boughey, Judy
    Tchou, Julia
    ANNALS OF SURGICAL ONCOLOGY, 2024, 31 (01) : S6 - S6
  • [32] Change in Biomarker Profile After Neoadjuvant Chemotherapy is Prognostic and Common Among Patients with HER2+Breast Cancer
    Tchou, Julia
    Gottipati, Soumy
    Goldbach, Macy
    Baxter, Molly
    Venters, Sara
    Balassanian, Ron
    Vohra, Poonam
    Gonzalves, Diego
    Ahmad, Zahra
    Nayak, Anupma
    Boughey, Judy C.
    Mukhtar, Rita A.
    Chen, Yunn-Yi
    ANNALS OF SURGICAL ONCOLOGY, 2024, 31 (12) : 8093 - 8101
  • [33] Neoadjuvant Therapy for Breast Cancer
    Murphy, Conleth
    ONCOLOGY-NEW YORK, 2009, 23 (11): : 20 - 27
  • [34] Neoadjuvant therapy for breast cancer
    Mangone, Lucia
    Mancuso, Pamela
    Tagliabue, Giovanna
    Filiberti, Rosa Angela
    Carrozzi, Giuliano
    Iacovacci, Silvia
    Mazzucco, Walter
    Tumino, Rosario
    Minicozzi, Pamela
    Sant, Milena
    Rossi, Paolo Giorgi
    TUMORI JOURNAL, 2019, 105 (06): : 488 - 493
  • [35] Neoadjuvant Therapy in Breast Cancer
    Bruges, Ricardo
    Hernan Guzman, Luis
    Sanchez, Oswaldo
    Diaz, Sandra
    Vergara, Edgar
    REVISTA COLOMBIANA DE CANCEROLOGIA, 2009, 13 (03): : 157 - 174
  • [36] Neoadjuvant Therapy for Breast Cancer
    Liu, Stephen V.
    Melstrom, Laleh
    Yao, Kathy
    Russell, Christy A.
    Sener, Stephen F.
    JOURNAL OF SURGICAL ONCOLOGY, 2010, 101 (04) : 283 - 291
  • [37] Neoadjuvant Therapy for Breast Cancer
    Zardavas, Dimitrios
    Piccart, Martine
    ANNUAL REVIEW OF MEDICINE, VOL 66, 2015, 66 : 31 - 48
  • [38] The Role of C-Reactive Protein as a Prognostic Biomarker in Patients with Early Breast Cancer Treated with Neoadjuvant Chemotherapy
    Edimiris-Herrmann, Alexandra
    Kolberg-Liedtke, Cornelia
    Bittner, Ann-Kathrin
    Hoffmann, Oliver
    Wetzig, Sarah
    Shaheen, Mohamed
    Stephanou, Miltiades
    Kolberg, Hans-Christian
    BREAST CARE, 2022, 17 (04) : 371 - 376
  • [39] Phase 2 Study of Ixabepilone Versus Paclitaxel as Neoadjuvant Therapy for Early Stage Breast Cancer with Comparative Biomarker Analysis
    Saura, C.
    Tseng, L-M
    Chan, S.
    Chacko, R. T.
    Campone, M.
    Liu, D.
    Mukhopadhyay, J.
    Mudenda, B.
    Horak, C.
    Xing, G.
    Pusztai, L.
    CANCER RESEARCH, 2010, 70
  • [40] Neoadjuvant therapy in patients with triple negative and HER2 positive early breast cancer
    Harbeck, N.
    BREAST, 2017, 32 : S18 - S18
12345